Performa HargaHarga kembali 1 minggu-1.42%
Harga kembali 1 Bulan6.09%
Harga kembali 3 Bulan21.51%
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)4.75
Harga Terendah (52 Minggu)3.18
Latar Belakang Perusahaan
Iovance Biotherapeutics berfokus pada pengembangan terapi imunoterapi berbasis sel untuk mengobati kanker.
Summary
Valuation Information
Current PE Ratio (TTM)-4.51
Forward PE Ratio-
Current Price to Book Value2.51
Current Price to Sales5.54
EV to Revenue5.68
EV to EBITDA-8.68
PEG Ratio-
Per Share
Current EPS (Annualized)-0.92
Diluted EPS (TTM)-0.92
Revenue Per Share0.74
Current Book Value Per Share1.64
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-321622016
Profit Margin-1.239
Operating Margin-1.135
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
